Clinical Trial Update: UB-421 in Combination With Optimized Background Regimen in Patients With Multi-drug Resistant HIV-1 Infection [Phase 3]

View source ↗

Summary

Phase 3 trial update for UB-421 combined with an optimized background regimen in patients with multi-drug resistant HIV-1 infection; study status not yet recrui…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• UB-421 (anti-CD4 antibody)

Snippet

Sponsor: United BioPharma | Conditions: HIV-1 Infection | Phase 3 | Status: NOT_YET_RECRUITING